Plasma C-reactive protein levels are associated with mortality in elderly with acute lung injury

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 524.e1-524.e6

  Komiya, Kosaku ^a,b   Ishii, Hiroshi ^a   Teramoto, Shinji ^c   Takahashi, Osamu ^d   Yamamoto, Hidehiko ^b   Oka, Hiroaki ^a   Umeki, Kenji ^a   Kadota, Jun ichi ^a  

^a OITA UNIVERSITY   (Japan)

^b ASO IIZUKA HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d St Luke's Life Science Institute   (Japan)

Author keywords

Acute lung injury; C reactive protein; Mortality

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; AGED; ARTICLE; BACTERIAL INFECTION; C REACTIVE PROTEIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; EMERGENCY WARD; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 84867331927     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.10.005     Document Type: Article

References (29)

1. Okamura J.M., Miyagi J.M., Terada K., et al. Potential clinical applications of C-reactive protein. J Clin Lab Anal 1990, 4:231-235.
2. Wood H.F., Mc C.M., Slater R.J. The occurrence during acute infections of a protein not normally present in the blood. V. Physical-chemical properties of the C-reactive protein crystallized by a modified technique. J Exp Med 1954, 100:71-79.
3. Lobo S.M., Lobo F.R., Bota D.P., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
4. Lim W.S., Baudouin S.V., George R.C., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64:55.
5. Chalmers J.D., Singanayagam A., Hill A.T. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008, 121:219-225.
6. Chiang C.H., Shih J.F., Su W.J., et al. Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome. Mayo Clin Proc 2004, 79:1372-1379.
7. Seki M., Watanabe A., Mikasa K., et al. Revision of the severity rating and classification of hospital-acquired pneumonia in the Japanese Respiratory Society guidelines. Respirology 2008, 13:880-885.
8. Japanese Respiratory S. Establishment of new severity ratings based on analysis of hospital-acquired pneumonia. Respirology 2009, 14:4-9.
9. Hyers T.M., Kew R.R., Krsek-Staples J., et al. Regulation of neutrophil function by acute phase reactants. Implications for resolution of the adult respiratory distress syndrome. Chest 1991, 99:7-9.
10. Bajwa E.K., Khan U.A., Januzzi J.L., et al. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 2009, 136:471-480.
11. Ware L.B. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006, 27:337-349.
12. Schmidt S.C., Hamann S., Langrehr J.M., et al. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study. J Hepatobiliary Pancreat Surg 2007, 14:484-492.
13. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
14. Global Initiative for Asthmxa Global strategy for asthma management and prevention Available at:, Accessed Oecember 11, 2011. http://www.ginasthma.com.
15. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated 2009), Accessed April 23, 2010. http://www.goldcopd.com/GuidelinesResources.asp?l1=2&l2=0.
16. Lee C.C., Chen S.Y., Tsai C.L., et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008, 29:322-327.
17. Buchta R., Fridkin M., Pontet M., et al. Modulation of human neutrophil function by C-reactive protein. Eur J Biochem 1987, 163:141-146.
18. Heuertz R.M., Piquette C.A., Webster R.O. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol 1993, 142:319-328.
19. Heuertz R.M., Ahmed N., Webster R.O. Peptides derived from C-reactive protein inhibit neutrophil alveolitis. J Immunol 1996, 156:3412-3417.
20. Abernathy V.J., Webster R.O., Dahms T.E. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. Am J Physiol 1996, 271:507-513.
21. Grad E., Golomb M., Mor-Yosef I., et al. Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. Am J Physiol Heart Circ Physiol 2007, 293:489-495.
22. Smith R.P., Lipworth B.J., Cree I.A., et al. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995, 108:1288-1291.
23. Hirakata Y., Yanagihara K., Kurihara S., et al. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia. Diagn Microbiol Infect Dis 2008, 61:170-174.
24. Hedlund J., Hansson L.O. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 2000, 28:68-73.
25. Niederman M.S. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin Infect Dis 2008, 47:127-132.
26. Parsons P.E., Matthay M.A., Ware L.B., Eisner M.D., National Heart LBI CTN Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005, 288:426-431.
27. McClintock D.E., Ware L.B., Eisner M.D., et al. Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med 2007, 175:256-262.
28. Goodman L.R., Fumagalli R., Tagliabue P., et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations. Radiology 1999, 213:545-552.
29. Desai S.R., Wells A.U., Suntharalingam G., et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary injury: a comparative CT study. Radiology 2001, 218:689-693.